205 related articles for article (PubMed ID: 20636342)
1. Quality control of fifteen probiotic products containing Saccharomyces boulardii.
Vanhee LM; Goemé F; Nelis HJ; Coenye T
J Appl Microbiol; 2010 Nov; 109(5):1745-52. PubMed ID: 20636342
[TBL] [Abstract][Full Text] [Related]
2. Influence of pH conditions on the viability of Saccharomyces boulardii yeast.
Graff S; Chaumeil JC; Boy P; Lai-Kuen R; Charrueau C
J Gen Appl Microbiol; 2008 Aug; 54(4):221-7. PubMed ID: 18802321
[TBL] [Abstract][Full Text] [Related]
3. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
[TBL] [Abstract][Full Text] [Related]
4. S-Adenosyl-L-methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death.
Cascio V; Gittings D; Merloni K; Hurton M; Laprade D; Austriaco N
BMC Microbiol; 2013 Feb; 13():35. PubMed ID: 23402325
[TBL] [Abstract][Full Text] [Related]
5. Saccharomyces boulardii viability and efficacy in horses with antimicrobial-induced diarrhoea.
Boyle AG; Magdesian KG; Durando MM; Gallop R; Sigdel S
Vet Rec; 2013 Feb; 172(5):128. PubMed ID: 23161811
[TBL] [Abstract][Full Text] [Related]
6. Review article: yeast as probiotics -- Saccharomyces boulardii.
Czerucka D; Piche T; Rampal P
Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
[TBL] [Abstract][Full Text] [Related]
7. Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea.
Dinleyici EC; Kara A; Dalgic N; Kurugol Z; Arica V; Metin O; Temur E; Turel O; Guven S; Yasa O; Bulut S; Tanir G; Yazar AS; Karbuz A; Sancar M; Erguven M; Akca G; Eren M; Ozen M; Vandenplas Y
Benef Microbes; 2015; 6(4):415-21. PubMed ID: 25653151
[TBL] [Abstract][Full Text] [Related]
8. A new, rapid multiplex PCR method identifies frequent probiotic origin among clinical Saccharomyces isolates.
Imre A; Rácz HV; Antunovics Z; Rádai Z; Kovács R; Lopandic K; Pócsi I; Pfliegler WP
Microbiol Res; 2019 Oct; 227():126298. PubMed ID: 31421716
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System.
Hudson LE; McDermott CD; Stewart TP; Hudson WH; Rios D; Fasken MB; Corbett AH; Lamb TJ
PLoS One; 2016; 11(4):e0153351. PubMed ID: 27064405
[TBL] [Abstract][Full Text] [Related]
10. Enhancing probiotic impact: engineering
de Carvalho BT; Subotić A; Vandecruys P; Deleu S; Vermeire S; Thevelein JM
Appl Environ Microbiol; 2024 Jun; 90(6):e0032524. PubMed ID: 38752748
[No Abstract] [Full Text] [Related]
11. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
[TBL] [Abstract][Full Text] [Related]
12. [Studies of viability and vitality after freezing of the probiotic yeast Saccharomyces boulardii: physiological preconditioning effect].
Pardo S; Galvagno MA; Cerrutti P
Rev Iberoam Micol; 2009 Jun; 26(2):155-60. PubMed ID: 19631167
[TBL] [Abstract][Full Text] [Related]
13. Saccharomyces boulardii CNCM I-745 in different clinical conditions.
Dinleyici EC; Kara A; Ozen M; Vandenplas Y
Expert Opin Biol Ther; 2014 Nov; 14(11):1593-609. PubMed ID: 24995675
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Two Forms of Loperamide-Simeticone and a Probiotic Yeast (Saccharomyces boulardii) in the Treatment of Acute Diarrhoea in Adults: A Randomised Non-Inferiority Clinical Trial.
Cottrell J; Koenig K; Perfekt R; Hofmann R;
Drugs R D; 2015 Dec; 15(4):363-73. PubMed ID: 26541878
[TBL] [Abstract][Full Text] [Related]
15. A Mutation in
Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
[TBL] [Abstract][Full Text] [Related]
16. Formulations for protecting the probiotic Saccharomyces boulardii from degradation in acidic condition.
Graff S; Chaumeil JC; Boy P; Lai-Kuen R; Charrueau C
Biol Pharm Bull; 2008 Feb; 31(2):266-72. PubMed ID: 18239285
[TBL] [Abstract][Full Text] [Related]
17. Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii.
Fietto JL; Araújo RS; Valadão FN; Fietto LG; Brandão RL; Neves MJ; Gomes FC; Nicoli JR; Castro IM
Can J Microbiol; 2004 Aug; 50(8):615-21. PubMed ID: 15467787
[TBL] [Abstract][Full Text] [Related]
18. Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.
Douradinha B; Reis VC; Rogers MB; Torres FA; Evans JD; Marques ET
Bioengineered; 2014; 5(1):21-9. PubMed ID: 24013355
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections.
Shan LS; Hou P; Wang ZJ; Liu FR; Chen N; Shu LH; Zhang H; Han XH; Han XX; Cai XX; Shang YX; Vandenplas Y
Benef Microbes; 2013 Dec; 4(4):329-334. PubMed ID: 24311316
[TBL] [Abstract][Full Text] [Related]
20. Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques.
Mitterdorfer G; Mayer HK; Kneifel W; Viernstein H
J Appl Microbiol; 2002; 93(4):521-30. PubMed ID: 12234334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
